Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response.

PubWeight™: 1.23‹?› | Rank: Top 10%

🔗 View Article (PMC 1581426)

Published in Proc Natl Acad Sci U S A on September 28, 2006

Authors

Ma-Li Wong1, Fiona Whelan, Panagiotis Deloukas, Pamela Whittaker, Marcos Delgado, Rita M Cantor, Samuel M McCann, Julio Licinio

Author Affiliations

1: Center on Pharmacogenomics, Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL 33136, USA. mali@miami.edu

Articles citing this

A whole genome association study of neuroticism using DNA pooling. Mol Psychiatry (2007) 2.30

A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. Arch Gen Psychiatry (2009) 2.15

Advances in targeting cyclic nucleotide phosphodiesterases. Nat Rev Drug Discov (2014) 1.86

When is pharmacogenetic testing for antidepressant response ready for the clinic? A cost-effectiveness analysis based on data from the STAR*D study. Neuropsychopharmacology (2009) 1.65

Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response. Mol Psychiatry (2008) 1.38

Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors. Clin Cancer Res (2008) 1.31

Association between SNPs and gene expression in multiple regions of the human brain. Transl Psychiatry (2012) 1.27

A new mouse model for the trisomy of the Abcg1-U2af1 region reveals the complexity of the combinatorial genetic code of down syndrome. Hum Mol Genet (2009) 1.20

Prediction of susceptibility to major depression by a model of interactions of multiple functional genetic variants and environmental factors. Mol Psychiatry (2012) 1.17

Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response. Arch Gen Psychiatry (2009) 1.15

Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans. Mol Psychiatry (2009) 1.08

Pharmacogenetics studies in STAR*D: strengths, limitations, and results. Psychiatr Serv (2009) 1.04

Discovery and replication of dopamine-related gene effects on caudate volume in young and elderly populations (N=1198) using genome-wide search. Mol Psychiatry (2011) 1.03

Phosphodiesterase 11A in brain is enriched in ventral hippocampus and deletion causes psychiatric disease-related phenotypes. Proc Natl Acad Sci U S A (2010) 0.99

Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid. Mol Psychiatry (2013) 0.96

Pharmacogenomics of antidepressant treatment effects. Dialogues Clin Neurosci (2011) 0.91

Fluoxetine pharmacogenetics in child and adult populations. Eur Child Adolesc Psychiatry (2012) 0.91

Clinical and molecular genetics of the phosphodiesterases (PDEs). Endocr Rev (2013) 0.89

Phosphodiesterase 11A (PDE11A) gene defects in patients with acth-independent macronodular adrenal hyperplasia (AIMAH): functional variants may contribute to genetic susceptibility of bilateral adrenal tumors. J Clin Endocrinol Metab (2012) 0.88

Genomic landscape of positive natural selection in Northern European populations. Eur J Hum Genet (2009) 0.86

Elevated stress-hemoconcentration in major depression is normalized by antidepressant treatment: secondary analysis from a randomized, double-blind clinical trial and relevance to cardiovascular disease risk. PLoS One (2008) 0.85

Appearance of antidepressant-like effect by sildenafil in rats after central muscarinic receptor blockade: evidence from behavioural and neuro-receptor studies. J Neural Transm (Vienna) (2007) 0.85

Treating COPD with PDE 4 inhibitors. Int J Chron Obstruct Pulmon Dis (2007) 0.83

Association of PDE11A global haplotype with major depression and antidepressant drug response. Neuropsychiatr Dis Treat (2009) 0.83

Association study of phosphodiesterase genes in the Sequenced Treatment Alternatives to Relieve Depression sample. Pharmacogenet Genomics (2009) 0.81

cGMP Signaling, Phosphodiesterases and Major Depressive Disorder. Curr Neuropharmacol (2011) 0.81

Genetic variation in phosphodiesterase (PDE) 7B in chronic lymphocytic leukemia: overview of genetic variants of cyclic nucleotide PDEs in human disease. J Hum Genet (2011) 0.79

PDE11A negatively regulates lithium responsivity. Mol Psychiatry (2016) 0.78

PDE11A regulates social behaviors and is a key mechanism by which social experience sculpts the brain. Neuroscience (2016) 0.77

Hippocampal protein expression is differentially affected by chronic paroxetine treatment in adolescent and adult rats: a possible mechanism of "paradoxical" antidepressant responses in young persons. Front Pharmacol (2013) 0.76

Phosphodiesterase Inhibitors as a Therapeutic Approach to Neuroprotection and Repair. Int J Mol Sci (2017) 0.75

Phosphodiesterase 11A (PDE11A), Enriched in Ventral Hippocampus Neurons, is Required for Consolidation of Social but not Nonsocial Memories in Mice. Neuropsychopharmacology (2016) 0.75

Articles cited by this

Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23

A rating scale for depression. J Neurol Neurosurg Psychiatry (1960) 90.89

From genotypes to genes: doubling the sample size. Biometrics (1997) 11.46

Highly parallel SNP genotyping. Cold Spring Harb Symp Quant Biol (2003) 9.10

Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry (2000) 9.02

Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev (1995) 5.45

Distribution of recombination crossovers and the origin of haplotype blocks: the interplay of population history, recombination, and mutation. Am J Hum Genet (2002) 4.29

Cyclic nucleotide research -- still expanding after half a century. Nat Rev Mol Cell Biol (2002) 4.16

Semaphorin 3A is a chemoattractant for cortical apical dendrites. Nature (2000) 3.57

PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem J (2003) 3.43

Conversion of neuronal growth cone responses from repulsion to attraction by cyclic nucleotides. Science (1998) 3.42

A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nat Genet (2006) 2.86

Phosphodiesterase isozymes: molecular targets for novel antiasthma agents. Am J Respir Crit Care Med (1998) 2.64

Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A. Proc Natl Acad Sci U S A (1999) 2.10

Phosphodiesterases in the CNS: targets for drug development. Nat Rev Drug Discov (2006) 2.10

Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase. Proc Natl Acad Sci U S A (1998) 2.00

Signal transduction underlying growth cone guidance by diffusible factors. Curr Opin Neurobiol (1999) 1.92

The lifetime history of major depression in women. Reliability of diagnosis and heritability. Arch Gen Psychiatry (1993) 1.87

Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A. Proc Natl Acad Sci U S A (2000) 1.86

A hospital-based twin register of the heritability of DSM-IV unipolar depression. Arch Gen Psychiatry (1996) 1.81

Multiple cyclic nucleotide phosphodiesterases. Mol Pharmacol (1994) 1.80

A comparison of three indicators for identifying Mexican Americans in epidemiologic research. Methodological findings from the San Antonio Heart Study. Am J Epidemiol (1986) 1.75

The biology of cyclic GMP-dependent protein kinases. J Biol Chem (2004) 1.75

Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase. J Biol Chem (1998) 1.72

Identification and characterization of a novel family of cyclic nucleotide phosphodiesterases. J Biol Chem (1998) 1.67

Recent progress in understanding the hormonal regulation of phosphodiesterases. Endocr Rev (1995) 1.67

Genetic risk factors for major depression in men and women: similar or different heritabilities and same or partly distinct genes? Psychol Med (2001) 1.66

Phosphodiesterase 5 inhibitors: current status and potential applications. Nat Rev Drug Discov (2002) 1.55

Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase. Biochem Biophys Res Commun (1998) 1.52

Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling. Trends Endocrinol Metab (2001) 1.47

Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme. Neuropsychopharmacology (2002) 1.45

PDE4 cAMP-specific phosphodiesterases. Prog Nucleic Acid Res Mol Biol (2001) 1.43

Major depressive disorder in a community-based twin sample: are there different genetic and environmental contributions for men and women? Arch Gen Psychiatry (1999) 1.41

Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans. Mol Psychiatry (2004) 1.36

Molecular cloning and characterization of human PDE8B, a novel thyroid-specific isozyme of 3',5'-cyclic nucleotide phosphodiesterase. Biochem Biophys Res Commun (1998) 1.36

Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms. Neuroscience (2004) 1.29

Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development. Cell Mol Life Sci (2005) 1.28

Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system. J Neurochem (1997) 1.26

Molecular biology of the cyclic AMP-specific cyclic nucleotide phosphodiesterases: a diverse family of regulatory enzymes. Cell Signal (1994) 1.26

Formation of olfactory memories mediated by nitric oxide. Nature (1997) 1.21

Inhibition of cyclic AMP phosphodiesterase (PDE4) reverses memory deficits associated with NMDA receptor antagonism. Neuropsychopharmacology (2000) 1.20

Effects of rolipram on scopolamine-induced impairment of working and reference memory in the radial-arm maze tests in rats. Psychopharmacology (Berl) (2000) 1.16

Phosphodiesterases and cyclic nucleotide signaling in endocrine cells. Mol Endocrinol (2000) 1.13

Mutant huntingtin affects the rate of transcription of striatum-specific isoforms of phosphodiesterase 10A. Eur J Neurosci (2004) 1.03

Distribution of cGMP-dependent protein kinase type I and its isoforms in the mouse brain and retina. Neuroscience (2005) 1.03

Adaptation in cyclic AMP signalling processes: a central role for cyclic AMP phosphodiesterases. Semin Cell Dev Biol (1998) 1.02

A heretical view on the role of NO and cGMP in vascular proliferative diseases. Trends Mol Med (2005) 0.98

Phosphodiesterase 11 (PDE11) regulation of spermatozoa physiology. Int J Impot Res (2005) 0.95

Genomic organization of the human phosphodiesterase PDE11A gene. Evolutionary relatedness with other PDEs containing GAF domains. Eur J Biochem (2001) 0.93

Identification of inhibitory and calmodulin-binding domains of the PDE1A1 and PDE1A2 calmodulin-stimulated cyclic nucleotide phosphodiesterases. J Biol Chem (1995) 0.91

Nitric oxide: an unconventional messenger in the nervous system of an orthopteroid insect. Arch Insect Biochem Physiol (2001) 0.90

Genetic factors in moderately severe and mild affective disorders. Arch Gen Psychiatry (1986) 0.87

Short- and long-term memory are differentially affected by metabolic inhibitors given into hippocampus and entorhinal cortex. Neurobiol Learn Mem (2000) 0.86

Protein kinase A and Rap1 levels in platelets of untreated patients with major depression. Mol Psychiatry (2001) 0.85

Involvement of beta-1 and beta-2 adrenergic receptors in the antidepressant-like effects of centrally administered isoproterenol. J Pharmacol Exp Ther (1994) 0.85

Chemotherapeutic potential of phosphodiesterase inhibitors. Curr Opin Chem Biol (1998) 0.83

Nature, nurture and depression: a twin study. Psychol Med (1991) 0.83

Neural network partitioning by NO and cGMP. J Neurosci (2001) 0.82

Involvement of hippocampal AMPA glutamate receptor changes and the cAMP/protein kinase A/CREB-P signalling pathway in memory consolidation of an avoidance task in rats. Braz J Med Biol Res (1997) 0.80

Articles by these authors

A second generation human haplotype map of over 3.1 million SNPs. Nature (2007) 85.39

Integrating common and rare genetic variation in diverse human populations. Nature (2010) 32.30

Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21

Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science (2007) 23.38

Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet (2008) 22.35

Genome-wide detection and characterization of positive selection in human populations. Nature (2007) 17.27

Genome-wide associations of gene expression variation in humans. PLoS Genet (2005) 17.27

Genome-wide association analysis identifies 20 loci that influence adult height. Nat Genet (2008) 16.92

A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet (2006) 15.63

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15

Functional impact of global rare copy number variation in autism spectrum disorders. Nature (2010) 14.66

Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet (2007) 14.05

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 13.23

Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet (2007) 12.62

Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron (2011) 10.61

Common variants conferring risk of schizophrenia. Nature (2009) 10.37

Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature (2011) 10.16

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23

A genotype calling algorithm for the Illumina BeadArray platform. Bioinformatics (2007) 8.03

Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02

Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44

Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature (2009) 7.39

Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet (2008) 7.33

Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am J Hum Genet (2008) 7.13

LDL-cholesterol concentrations: a genome-wide association study. Lancet (2008) 6.44

Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet (2011) 5.56

Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet (2009) 5.32

Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains. Genome Res (2010) 5.08

Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet (2009) 4.61

A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose. PLoS Genet (2009) 4.32

Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet (2009) 4.30

Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol (2010) 4.08

Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73

Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet (2010) 3.58

A genome-wide scan for common alleles affecting risk for autism. Hum Mol Genet (2010) 3.42

Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet (2009) 3.42

Bayesian refinement of association signals for 14 loci in 3 common diseases. Nat Genet (2012) 3.31

Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21

Genetic variation in LIN28B is associated with the timing of puberty. Nat Genet (2009) 3.09

Modeling of the temporal patterns of fluoxetine prescriptions and suicide rates in the United States. PLoS Med (2006) 3.03

Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. Nat Genet (2010) 2.99

Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nat Genet (2004) 2.86

A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. Am J Hum Genet (2005) 2.85

Collaborative meta-analysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture. Ann Intern Med (2009) 2.80

A genome-wide association study of testicular germ cell tumor. Nat Genet (2009) 2.79

The impact of SNP density on fine-scale patterns of linkage disequilibrium. Hum Mol Genet (2004) 2.78

Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer. Nature (2012) 2.66

Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy. Hum Mol Genet (2002) 2.65

A genome-wide survey of the prevalence and evolutionary forces acting on human nonsense SNPs. Am J Hum Genet (2009) 2.62

A genomewide screen of 345 families for autism-susceptibility loci. Am J Hum Genet (2003) 2.51

Individual common variants exert weak effects on the risk for autism spectrum disorderspi. Hum Mol Genet (2012) 2.46

Genetic variation near the hepatocyte nuclear factor-4 alpha gene predicts susceptibility to type 2 diabetes. Diabetes (2004) 2.43

Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci U S A (2004) 2.41

Evidence for a language quantitative trait locus on chromosome 7q in multiplex autism families. Am J Hum Genet (2001) 2.29

Clinical outcomes and genome-wide association for a brain methylation site in an antidepressant pharmacogenetics study in Mexican Americans. Am J Psychiatry (2014) 2.26

Evidence for sex-specific risk alleles in autism spectrum disorder. Am J Hum Genet (2004) 2.24

High-throughput genotyping of Salmonella enterica serovar Typhi allowing geographical assignment of haplotypes and pathotypes within an urban District of Jakarta, Indonesia. J Clin Microbiol (2008) 2.14

Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet (2012) 2.12

A quantitative trait locus analysis of social responsiveness in multiplex autism families. Am J Psychiatry (2007) 2.09

Common variants in the region around Osterix are associated with bone mineral density and growth in childhood. Hum Mol Genet (2009) 1.99

The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90

Leptin replacement alters brain response to food cues in genetically leptin-deficient adults. Proc Natl Acad Sci U S A (2007) 1.89

Association of stearoyl-CoA desaturase 1 activity with familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol (2008) 1.81

Ecological studies of antidepressant treatment and suicidal risks. Harv Rev Psychiatry (2007) 1.78

Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab (2005) 1.77

Neuroendocrine control of body fluid metabolism. Physiol Rev (2004) 1.67

Phenotypic manifestations of MECP2 mutations in classical and atypical Rett syndrome. Am J Med Genet A (2004) 1.63

Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc Natl Acad Sci U S A (2010) 1.63

Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity. Proc Natl Acad Sci U S A (2004) 1.61

Changes in insulin sensitivity during leptin replacement therapy in leptin-deficient patients. Am J Physiol Endocrinol Metab (2008) 1.60

Search for autism loci by combined analysis of Autism Genetic Resource Exchange and Finnish families. Ann Neurol (2006) 1.57

A susceptibility locus for migraine with aura, on chromosome 4q24. Am J Hum Genet (2002) 1.55

Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function. J Am Coll Cardiol (2006) 1.52

Social responsiveness, an autism endophenotype: genomewide significant linkage to two regions on chromosome 8. Am J Psychiatry (2014) 1.50

Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility. PLoS Genet (2011) 1.49

Familial combined hyperlipidemia in Mexicans: association with upstream transcription factor 1 and linkage on chromosome 16q24.1. Arterioscler Thromb Vasc Biol (2005) 1.46

Genome scans provide evidence for low-HDL-C loci on chromosomes 8q23, 16q24.1-24.2, and 20q13.11 in Finnish families. Am J Hum Genet (2002) 1.45

Biochemical and genetic association of plasma apolipoprotein A-II levels with familial combined hyperlipidemia. Circ Res (2003) 1.44

Effect of leptin replacement on brain structure in genetically leptin-deficient adults. J Clin Endocrinol Metab (2005) 1.44

A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder. Hum Genet (2011) 1.43

Genetic linkage of attention-deficit/hyperactivity disorder on chromosome 16p13, in a region implicated in autism. Am J Hum Genet (2002) 1.39

A genomewide scan for attention-deficit/hyperactivity disorder in an extended sample: suggestive linkage on 17p11. Am J Hum Genet (2003) 1.36

Oxytocin induces differentiation of P19 embryonic stem cells to cardiomyocytes. Proc Natl Acad Sci U S A (2002) 1.36

Gene expression changes with age in skin, adipose tissue, blood and brain. Genome Biol (2013) 1.34

Population-specific risk of type 2 diabetes conferred by HNF4A P2 promoter variants: a lesson for replication studies. Diabetes (2008) 1.33

Facilitating genome navigation: survey sequencing and dense radiation-hybrid gene mapping. Nat Rev Genet (2005) 1.33

Detection, imputation, and association analysis of small deletions and null alleles on oligonucleotide arrays. Am J Hum Genet (2008) 1.27

Leptin replacement improves cognitive development. PLoS One (2008) 1.27

Genomic study in Mexicans identifies a new locus for triglycerides and refines European lipid loci. J Med Genet (2013) 1.26

Cross-species analyses implicate Lipin 1 involvement in human glucose metabolism. Hum Mol Genet (2005) 1.25

Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia. Proc Natl Acad Sci U S A (2005) 1.24